Etanercept: Revizyonlar arasındaki fark
| [kontrol edilmemiş revizyon] | [kontrol edilmemiş revizyon] |
İçerik silindi İçerik eklendi
Luckas-bot (mesaj | katkılar) k Bot değişikliği Ekleniyor: ja:エタネルセプト |
Khutuck Bot (mesaj | katkılar) k Bot: Kozmetik değişiklikler |
||
9. satır:
== Kaynaklar ==
* ^ Braun J, McHugh N, Singh A, Wajdula JS, Sato R (2007). "Improvement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept 50 mg once-weekly and 25 mg twice-weekly". Rheumatology (Oxford) 46 (6): 999–1004. doi:10.1093/rheumatology/kem069. PMID 17389658.
* ^ TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases - Nature Medicine. Retrieved on 2008-01-10.
* ^ Arthritis Drug Effective for Depression in Psoriasis Sufferers. Retrieved on 2008-01-10.
* ^ Smith KJ, Skelton HG (2001). "Rapid onset of cutaneous squamous cell carcinoma in patients with rheumatoid arthritis after starting tumor necrosis factor alpha receptor IgG1-Fc fusion complex therapy". J. Am. Acad. Dermatol. 45 (6): 953–6. doi:10.1067/mjd.2001.117725. PMID 11712048.
* ^ Madhusudan S, Muthuramalingam SR, Braybrooke JP, et al (2005). "Study of etanercept, a tumor necrosis factor-alpha inhibitor, in recurrent ovarian cancer". J. Clin. Oncol. 23 (25): 5950–9. doi:10.1200/JCO.2005.04.127. PMID 16135466.
* ^ Enbrel and Humira Now Have Automated Delivery System. Retrieved on 2008-01-10.
* ^ Prescribing Information - ENBREL. Retrieved on 2008-01-10.
* ^ FDA Clinical Trials database
* ^ "Etanercept plus standard therapy for Wegener's granulomatosis" (2005). N. Engl. J. Med. 352 (4): 351–61. doi:10.1056/NEJMoa041884. PMID 15673801.
* Tobinick Edward L., Gross H, Weinberger A, Cohen H (2006). "TNF-alpha modulation for treatment of Alzheimer's disease: a 6-month pilot study". MedGenMed 8 (2): 25. PMID 16926764.
* Tobinick Edward L., Gross H. (2008). "Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration". J. Neuroinflammation 5 (2). doi:10.1186/1742-2094-5-2. PMID 18184433.
{{İmmunosupresantlar}}
| |||